Lab test picks your chemo: new hope to stop Cancer's return
NCT ID NCT07296666
Summary
This study is for people who have had surgery for stage II or III bile duct cancer. It aims to see if using a lab test to choose personalized chemotherapy drugs is better at preventing the cancer from coming back than using the standard single-drug chemotherapy. About 98 participants will be randomly assigned to receive either the personalized combination or the standard treatment for 8 cycles.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.